Pallas Health vs Refills: Clinician Choice or Flat Pricing Debate
Pallas Health vs Refills: which fits your needs faster? Early verdict: choose Pallas Health if you want a clinician to pick between FDA-approved brand-name GLP-1s and compounded preparations; choose Refills if you prioritize flat, low monthly pricing and month-to-month service.
Explore Pallas Health plans and clinician review
Pricing model and starting costs compared
Price is the clearest contrast between Pallas Health vs Refills. Pallas lists compounded semaglutide at $139 for the first month, then $597 every 12 weeks, which the source frames as a $199/month average. Compounded tirzepatide is $179 first month, then $897 every 12 weeks, a $299/month average. Pallas also offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro as cash-pay options with higher monthly cash prices listed on the site.
See Refills flat-price options from $99/mo
Refills emphasizes flat pricing at every dosage, advertising compounded GLP-1 from $99/month (~$5/day) and tirzepatide from $159/month. Refills says the same low price applies at every dosage and that plans are month-to-month, cancel anytime.
Medication selection and regulatory notes
On medication options, Pallas Health presents both FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Pallas states that compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Refills focuses on personalized compounded GLP-1 and notes compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA.
How clinical review and care differ
Both providers require a clinician review, but the workflows differ. Pallas Health says a US-licensed clinician reviews your health history and personalizes the plan and that care is included in one all-in plan price with ongoing check-ins and messaging and no membership fee. Pallas notes asynchronous care in most states and that a video visit is required in seven states plus Washington, D.C.
Refills describes a 3-minute intake quiz followed by a licensed clinician review; you may either have a chat with a doctor or receive a prescription directly within 24 hours depending on need. Refills highlights unlimited access to the patient care team and clinicians at no extra cost and a 24/7 health concierge.
Availability, shipping, and cancellation
Pallas advertises 100% online delivery, free expedited and discreet shipping, and that compounded medications are prepared by US-licensed compounding pharmacies. Pallas is cash-pay only and does not bill insurance. It also notes compounded plans renew every 12 weeks rather than monthly, so cancellation timing matters.
Refills states availability in all 50 US States, free discreet shipping, and month-to-month billing with the ability to cancel anytime and no cancellation fees. Refills also references partner clinician networks and that compounded products require a prescription.
Distinctive supported differences
- Pricing approach: Pallas uses an intro lower first-month price then 12-week renewal pricing; Refills uses flat monthly pricing at every dosage from $99/mo.
- Medication scope: Pallas offers both FDA-approved brand-name GLP-1s and compounded options; Refills emphasizes compounded GLP-1 and GIP+GLP-1 dual agonist availability.
- Care model and state requirements: Pallas is asynchronous in most states but requires video visits in some; Refills offers a quiz-based intake with chat or direct prescription within 24 hours and is available in all 50 states per the source.
- Billing cadence: Pallas compounded plans renew every 12 weeks; Refills is month-to-month with monthly supply shipping.
| Criteria | Pallas Health | Refills |
|---|---|---|
| Starting price | $139 first month for compounded semaglutide | $99/month for compounded semaglutide |
| Pricing model | Intro first month then renews every 12 weeks; compound plans priced by medication | Flat monthly price, same at every dosage; month-to-month |
| Medication options | FDA-approved brand-name GLP-1s or clinician-personalized compounded options | Compounded GLP-1s and GIP+GLP-1 dual agonist available |
| Care and clinician review | US-licensed clinician personalizes plan; ongoing check-ins and messaging included | Licensed clinician reviews intake; chat or direct prescription within 24 hours; 24/7 concierge |
| Availability and shipping | 100% online, free expedited discreet shipping; some states require video visit | Available in all 50 US States, free discreet shipping, month-to-month |
Check Pallas Health clinician options
Other considerations from the sources
Both sources explicitly state that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Pallas notes that compounded medications are prepared by US-licensed compounding pharmacies and that the medication received may differ in appearance from images. Refills states compounding pharmacies are licensed and inspected and mentions third-party USP testing on the landing evidence.
Start Refills intake quiz and pricing details
Conclusion and final recommendation
Across the Pallas Health vs Refills comparison the decision hinges on whether you value clinician-guided access to brand and compounded GLP-1s or the simplicity of flat, low monthly pricing. Pallas bundles clinician care, check-ins, and messaging into an all-in plan and offers both brand-name and compounded choices with a first-month intro price then 12-week renewals. Refills centers on flat pricing at every dose from $99/month, month-to-month billing, and 24/7 concierge support.
Choose Pallas Health if you want a US-licensed clinician to select between FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide, and if you accept 12-week compound renewals and cash-pay only pricing.
Choose Refills if you prioritize the lowest flat monthly rate at every dosage, month-to-month billing with the ability to cancel anytime, and nationwide availability in all 50 US States.